Press Releases

Press Releases

Share
Share
and/or
515 News Releases found
A medal that says 2024 LBGTQ+ Healthcare Equality Leader, over a photo of a person holding a small Pride flag
MSK Recognized for Commitment to LGBTQ+ Community
MSK has been recognized as an LGBTQ+ Healthcare Equality Leader from the Human Rights Campaign Foundation on its 2024 Healthcare Equity Index (HEI).
Iconic New York Brands Come Together to Support Memorial Sloan Kettering Cancer Center
Iconic New York Brands Come Together to Support Memorial Sloan Kettering Cancer Center
NYC for MSK will unite New Yorkers and some of the most iconic New York brands to commemorate Memorial Sloan Kettering Cancer Center’s 140th Anniversary.
Memorial Sloan Kettering Cancer Center Issues Statement on the First Quarter of 2024 Financial Results
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its first quarter of 2024 results.
Comedy vs Cancer sells out Jazz at Lincoln Center
Comedy vs Cancer sells out Jazz at Lincoln Center
Nick Kroll, Tina Fey, John Oliver, Jim Gaffigan, and other comedians team up with Memorial Sloan Kettering Cancer Center to outwit blood cancers.
Memorial Sloan Kettering Celebrates Exceptional Service in Nursing: 2024 Robbins Family Awards
Memorial Sloan Kettering Celebrates Exceptional Service in Nursing: 2024 Robbins Family Awards
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 – 12).
Memorial Sloan Kettering Cancer Center Launches Innovative Projects to Improve Health in Queens and Brooklyn
Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK’s deep experience in cancer science and discovery, community engagement, and compassionate patient care.
MSK Awards & Appointments January 2023
MSK Awards and Appointments April 2024
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Memorial Sloan Kettering Cancer Center Issues Statement on Fiscal Year 2023 Financial Results
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2023 results.
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
Jeffrey Drebin, MD, PhD, Named President-Elect of the American Surgical Association
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer Vaccine May Elicit Lasting Immune Response in Patients with Pancreatic Cancer Add to Default shortcuts
New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer Vaccine May Elicit Lasting Immune Response in Patients with Pancreatic Cancer
New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after surgery.